Pharmacotherapy of Gastrointestinal and Endocrine Disorders

/in /by

Pharmacotherapy of Gastrointestinal and Endocrine Disorders

Module 5 Overview

Introduction

This week we will focus on the pharmacotherapeutics of gastrointestinal and endocrine disorders, including commonly occurring conditions and their commonly prescribed medications.  As you review this week’s content consider the impact of comorbid disease on each condition.  It is not unusual to encounter a patient who has underlying cardiovascular disease in the presence of diabetes.  Think about the impact of pharmacotherapeutics on all organ systems Pharmacotherapy of Gastrointestinal and Endocrine Disorders.

ORDER A PLAGIARISM FREE PAPER NOW

Learning Objectives

After completing this module, you will be able to:

  • Utilize advanced nursing and pharmacological interventions in gastrointestinal, renal and endocrine disorders to resolve complex and biological, psychological, physiological and pathophysiologic conditions. Pharmacotherapy of Gastrointestinal and Endocrine Disorders
  • Teach patients, family members, and others from diverse populations regarding safe and effective use of drugs and natural products in gastrointestinal, renal and endocrine disorders.

Reading & Resources

  • Read Chapters 28-31 and 46-47.  In Arcangelo, V. P., & Peterson, A. M. (2017). Pharmacotherapeutics for advanced practice: A practical approach (4th ed.). Philadelphia, PA: Wolters Kluwer/Lippincott Williams & Wilkins.
  • American Diabetes Association (2017). Standards of medical care in diabetes—2018 abridged for primary care providers. Clinical Diabetes, 36(1), 14–37. doi:10.2337/cd17-0119. Retrieved from http://clinical.diabetesjournals.org/content/36/1/14

Learning Activities

  • Discussion: Participate in Discussion 5. Remember there are two cases and if your last name begins with A-L complete case 1 and reply to two peers in case 2.  If your last name begins with M-Z complete case two and reply to two peers in case 1.
  • Test: Complete Progress Test 3. Click on the Progress Test 3 link for more details. Pharmacotherapy of Gastrointestinal and Endocrine Disorders

Discussion 5

This week if your last name begins with A-L complete case 1 and reply to two peers in case 2.  If your last name begins with M-Z complete case 2 and reply to two peers in case 1.

Case 1:

C. J. is a 55-year-old Hmong postmenopausal woman presenting with Type II diabetes mellitus, hypertension and urinary incontinence. She reports that she often cannot get to the bathroom in time when she feels the urge to urinate. She also wets herself when she laughs or sneezes. She is very embarrassed about this problem and has decreased her excursions from the house because of it. She drinks six cups of coffee a day. She does not follow a special diet, She takes hydrochlorothiazide for hypertension, and metformin for DM. Today her HgbA1C is 12.  She wants treatment for her urinary complaints Pharmacotherapy of Gastrointestinal and Endocrine Disorders.

Diagnosis: Uncontrolled Type II DM, HTN, and urinary incontinence

In this discussion forum:

  1. Discuss specific goals for pharmacotherapy for treating C. J..
  2. Discuss the drug therapy a CNP would likely prescribe and why.
  3. Discuss the parameters for monitoring success of the therapy.
  4. Discuss health promotion recommendations you would consider for C. J.
  5. Pharmacotherapy of Gastrointestinal and Endocrine Disorders

Case 2:

Mr. Z is a 36-year-old construction worker who presents to the nurse with fatigue and a foot ulcer. He is a smoker with type 1 diabetes for 25 years, and he take 20 units of

70/30 insulin twice a day. He lost his meter a year ago. He is very thin, although he eats constantly on the job because he is worried about hypoglycemia; he cannot remember the last time he had hypoglycemia, but it was years ago. Pharmacotherapy of Gastrointestinal and Endocrine Disorders He recently received a call from the office because his TSH level was greater than 10 and he was told he has “thyroid” problems.  He thinks this may be the cause of his fatigue.

In this discussion forum:

  1. Discuss specific goals for pharmacotherapy for treating Mr Z
  2. Discuss the drug therapy a CNP would likely prescribe and why.
  3. Discuss the parameters for monitoring success of the therapy.
  4. Discuss health promotion recommendations you would consider for Mr Z.
  5. Pharmacotherapy of Gastrointestinal and Endocrine Disorders

Remember to respond to at least two of your peers. Please see the Course Syllabus for Discussion Participation Requirements and Grading Criteria.